Biocon files Prospectus for Syngene IPO

India Infoline News Service | Mumbai | April 23, 2015 08:30 IST

Under the proposed issue, shares will be offered through an offer for sale (OFS) route by Biocon Limited upto 22,000,000 equity shares of face value of Rs. 10 each for cash and at such premium as may be determined. The offer includes a reservation of 2,000,000 Equity Shares for Biocon Shareholders.

Biocon Limited
Biocon Ltd has announced that Syngene international Limited, a subsidiary of the Company has proposed public issue of its equity shares through 100% book building method in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and has filed a Draft Red Herring Prospectus with the Securities and Exchange Board of India on April 22, 2015.
Under the proposed issue, shares will be offered through an offer for sale (OFS) route by Biocon Limited upto 22,000,000 equity shares of face value of Rs. 10 each for cash and at such premium as may be determined. The offer includes a reservation of 2,000,000 Equity Shares for Biocon Shareholders.
Biocon Ltd
BSE 637.55 [2] ([0.31]%)
NSE 637.55 [2.05] ([0.32]%)

***Note: This is a NSE Chart

 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.